Bicycle Therapeutics (BCYC) Total Current Liabilities (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Total Current Liabilities data on file, last reported at $47.6 million in Q2 2026.

• Quarterly Total Current Liabilities fell 38.47% year-over-year to $47.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $47.6 million (down 38.47% YoY) and the FY2025 annual result came in at $57.0 million, down 15.24% from the prior year.
• Total Current Liabilities slipped to $47.6 million in Q2 2026, from $48.9 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $77.4 million in Q2 2025 to a low of $35.4 million in Q1 2022.
• A 5-year average of $57.6 million and a median of $56.7 million in 2024 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities surged 77.64% — and 2026, when it plunged 38.47%.
• Tracing BCYC's Total Current Liabilities over 5 years: stood at $53.3 million in 2022, then surged by 30.36% to $69.5 million in 2023, then dropped by 3.32% to $67.2 million in 2024, then slipped by 15.24% to $57.0 million in 2025, then slipped by 16.41% to $47.6 million in 2026.
• The last three Total Current Liabilities figures came in at $47.6 million (Q2 2026), $48.9 million (Q1 2026), and $57.0 million (Q4 2025), per Business Quant data.